drugset / Trial / NCT02961231

Evaluation of PCV Schedules in a Naive Population in Vietnam

NCT02961231

RandomizedParallel-groupOpen-labelPrevention

Summary

The cost of pneumococcal conjugate vaccine use can be greatly reduced by making use of existing herd immunity to protect children against vaccine type pneumococci. The investigators will reduce the circulation of vaccine type pneumococci to low levels by PCV catch-up campaign; vaccinating all children less than 3 years of age with PCV, after which the investigators will evaluate the ability of a simplified two doses regimen and an alternative one dose regimen to prevent the reintroduction of vaccine type pneumococci compared to the WHO recommended 2 doses schedule.

Timeline

Start
2016-10-01
Primary completion
2020-11-30
Completion
2023-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Synflorix Vaccine